Incidence of respiratory syncytial virus infection in children with congenital heart disease undergoing immunoprophylaxis with palivizumab in Pará state, north region of Brazil

Incidence of respiratory syncytial virus infection in children with congenital heart disease undergoing immunoprophylaxis with palivizumab in Pará state, north region of Brazil

Abstract Background Palivizumab prophylaxis for the human respiratory syncytial virus (HRSV) has been reported to reduce the risk of hospital admissions related to HRSV in children with congenital heart disease (CHD). These children are at high risk of developing severe lower respiratory tract infec...

Full description

Bibliographic Details
Main Authors: Roseane Porfírio de Souza, Andre Luis Ribeiro Ribeiro, Sílvio Augusto Fernandes de Menezes, Luiz Fernando Almeida Machado
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Pediatrics
Subjects:
Respiratory syncytial virus
Immunization
Palivizumab
Respiratory tract infections
Online Access:http://link.springer.com/article/10.1186/s12887-019-1681-6

Internet

http://link.springer.com/article/10.1186/s12887-019-1681-6

Similar Items